logo-loader
viewErgomed PLC

Ergomed reveals it is providing clinical research services for a study in Italy for the treatment of patients with coronavirus

The group noted that the study is sponsored by the Papa Giovanni XXIII Hospital in Bergamo, Italy and supported by EUSA Pharma (EUSA)

Ergomed PLC -
In early morning trading, Ergomed shares were 11.4% higher at 312p

Ergomed PLC (LON:ERGO) shares jumped on Wednesday as the firm revealed it is providing clinical research services for a study in Italy for the treatment of patients with coronavirus (COVID-19).

In a statement, the AIM-listed company which is focused on providing specialised services to the pharmaceutical industry, today announced the initiation of a study of siltuximab, an interleukin (IL)-6 targeted monoclonal antibody, for the treatment of patients with COVID-19 who have developed serious respiratory complications.

READ: Ergomed's underlying earnings set to top expectations after a strong year

The group noted that the study is sponsored by the Papa Giovanni XXIII Hospital in Bergamo, Italy and supported by EUSA Pharma (EUSA).

Ergomed said it is providing clinical research services for the study and has been integrally involved in the design and implementation of the study from a clinical and operational perspective.

Dr Miroslav Reljanović, Ergomed’s executive chairman commented: "COVID-19 represents an unprecedented global healthcare challenge and the rapid evaluation of therapies which could alter the course of the infection and improve outcomes for patients is vital.

“Ergomed is proud to be making a contribution to this effort by bringing our proven capabilities and expertise to bear on this important study."

In early morning trading, Ergomed shares were 11.4% higher at 312p.

Quick facts: Ergomed PLC

Price: 367.5 GBX

AIM:ERGO
Market: AIM
Market Cap: £177.14 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ergomed PLC named herein, including the promotion by the Company of Ergomed PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: FTSE 100 makes positive start to trading despite further...

Headlines from the Proactive UK newsroom. Oil prices have dropped further after Saudi Arabia and Russia postponed a meeting to discuss production cuts. The two countries started an oil price war last month. Rolls-Royce has built a cash pile of £6.7bn in anticipation of a further...

on 6/4/20

2 min read